Objectives

After participating in this educational activity, attendees should be able to:
1. Review the various presentations of mucormycosis
2. Discuss treatment options for the management of mucormycosis
3. Discuss the evidence supporting the use of isavuconazole in the treatment of mucormycsis

Faculty

Brandon Opitz, PharmD
PGY2 Infectious Diseases Pharmacy Resident
Pharmacist
Baystate Medical Center
 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.